Prognostic Significance of Occult Metastases Detected by Sentinel Lymphadenectomy and Reverse Transcriptase–Polymerase Chain Reaction in Early-Stage Melanoma Patients

作者: Peter J. Bostick , Donald L. Morton , Roderick R. Turner , Kelly T. Huynh , He-Jing Wang

DOI: 10.1200/JCO.1999.17.10.3238

关键词: Sentinel nodeH&E stainMelanomaMedicinePathologyMART-1 AntigenImmunohistochemistryMetastasisLymphadenectomyMicrometastasis

摘要: PURPOSE: Detection of micrometastases in the regional tumor-draining lymph nodes is critical for accurate staging and prognosis in melanoma patients. We hypothesized that a multiple-mRNA marker (MM) reverse transcriptase–polymerase chain reaction (RT-PCR) assay would improve the detection of occult metastases in the sentinel node (SN), compared with hematoxylin and eosin (H&E) staining and immunohistochemistry (IHC), and that MM expression is predictive of disease relapse. PATIENTS AND METHODS: Seventy-two consecutive patients with clinical early-stage melanoma underwent sentinel lymphadenectomy (SLND). Their SNs were serially sectioned and assessed for MAGE-3, MART-1, and tyrosinase mRNA expression by RT-PCR, in parallel with H&E staining and IHC, for melanoma metastases. MM expression in the SNs was correlated with H&E and IHC assay results, standard prognostic factors, and disease-free survival. RESULTS: In 17 patients with H&E- and/or IHC-positive SNs, 16 (94%) expressed two or more mRNAmarkers. Twenty (36%) of 55 patients with histopathologically negative SNs expressed two or more mRNA markers. By multivariate analysis, patients at increased risk of metastases to the SN had thicker lesions (P = .03), were 60 years of age or younger (P < .05), and/or were MM-positive (P < .001). Patients with histopathologically melanoma-free SNs who were MM-positive, compared with those who were positive for one or fewer mRNA markers, were at increased risk of recurrence (P = .02). Patients who were MM-positive with histopathologically proven metastases in the SN were at greatest risk of disease relapse (P = .01). CONCLUSION: H&E staining and IHC underestimate the true incidence of melanoma metastases. MM expression in the SN more accurately reflects melanoma micrometastases and is also a more powerful predictor of disease relapse than are H&E staining and IHC alone.

参考文章(28)
Terry Sarantou, Andrew J. Conrad, Donald L. Morton, Dave S. B. Hoon, Dorcas D. J. Chi, Peter Schmid, Darryl A. Garrison, Melanoma-associated Antigens as Messenger RNA Detection Markers for Melanoma Cancer Research. ,vol. 57, pp. 1371- 1376 ,(1997)
Christine T Kuo, Peter J Bostick, Reiko F Irie, Donald L Morton, Andrew J Conrad, DS Hoon, Assessment of messenger RNA of beta 1-->4-N-acetylgalactosaminyl-transferase as a molecular marker for metastatic melanoma. Clinical Cancer Research. ,vol. 4, pp. 411- 418 ,(1998)
DD Chi, Randall E Merchant, Robert Rand, Andrew J Conrad, Darryl Garrison, Roderick Turner, Donald L Morton, DS Hoon, Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas. American Journal of Pathology. ,vol. 150, pp. 2143- 2152 ,(1997)
P J Bostick, S Chatterjee, D D Chi, K T Huynh, A E Giuliano, R Cote, D S Hoon, Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. Journal of Clinical Oncology. ,vol. 16, pp. 2632- 2640 ,(1998) , 10.1200/JCO.1998.16.8.2632
D S Hoon, Y Wang, P S Dale, A J Conrad, P Schmid, D Garrison, C Kuo, L J Foshag, A J Nizze, D L Morton, Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. Journal of Clinical Oncology. ,vol. 13, pp. 2109- 2116 ,(1995) , 10.1200/JCO.1995.13.8.2109
D. L. Morton, A. Barth, Vaccine therapy for malignant melanoma CA: A Cancer Journal for Clinicians. ,vol. 46, pp. 225- 244 ,(1996) , 10.3322/CANJCLIN.46.4.225
Constantine P. Karakousis, Augustine F. Velez, James E. Spellman, Jennifer Scarozza, The technique of sentinel node biopsy European Journal of Surgical Oncology (EJSO). ,vol. 22, pp. 271- 275 ,(1996) , 10.1016/S0748-7983(96)80017-5
John M Kirkwood, Adjuvant IFNα2 therapy of melanoma The Lancet. ,vol. 351, pp. 1901- 1903 ,(1998) , 10.1016/S0140-6736(05)78608-6
DONALD L. MORTON, LESLIE WANEK, J. ANNE NIZZE, ROBERT M. ELASHOFF, JAN H. WONG, Improved Long-term Survival After Lymphadenectomy of Melanoma Metastatic to Regional Nodes Annals of Surgery. ,vol. 214, pp. 491- 501 ,(1991) , 10.1097/00000658-199110000-00013